DAUNOrubicin citrate liposomal

DAUNOrubicin citrate liposomal

[dô′nōro̅o̅′bisin]
an anthracycline antibiotic antineoplastic agent.
indication It is prescribed in the treatment of advanced Kaposi's sarcoma in HIV patients.
contraindications Known hypersensitivity to this drug prohibits its use. It is also contraindicated in pregnancy, during lactations and in patients with systemic infections or cardiac disease.
adverse effects Serious adverse effects include chest pain and edema.